Women in biopharma 2025 - 20 women leading biopharma R&D

Through exclusive interviews and in-depth profiles, we’ll highlight women who are not just contributing to biopharma’s growth, but actively steering its direction toward a more equitable and dynamic future. Their stories shine a light on progress made, challenges overcome, and the opportunities still ahead.

From breakthrough research to boardroom leadership, these honorees are shaping conversations that matter — setting new standards, championing diversity, and inspiring the next generation of talent in life sciences.

11:00 AM - 11:10 AM ET

Welcome remarks & honorees revealed

Nicole DeFeudis

Editor

Endpoints News

11:10 AM - 11:40 AM ET

In the lab with CSOs

Chief scientific officers play a key role in defining a company’s mission and guiding research and development efforts. Join a group of CSOs, including current and past honorees, for a discussion about their experiences steering cutting-edge science and the difficult decisions they’ve made along the way.

2025 Honoree

TBA

Jayashree Aiyar

CSO

Syngene International

Laura Sepp-Lorenzino

Biotech Executive

Intellia Therapeutics

Nicole DeFeudis

Moderator

Editor

Endpoints News

11:45 AM - 12:15 PM ET

Why does community matter?

Network organizations like the Biotech CEO Sisterhood and Women in Bio provide resources to women in the industry at various stages of their careers. These efforts are gaining visibility — including at this year’s JP Morgan Healthcare Conference, where the Biotech CEO Sisterhood organized an event to flood Union Square in pink. What have women in biopharma gained from banding together to build community, and what challenges have they faced?